Literature DB >> 7742445

Lues maligna, or ulceronodular syphilis, in a man infected with human immunodeficiency virus: case report and review.

M Sands1, A Markus.   

Abstract

A 30-year-old bisexual man who was infected with human immunodeficiency virus (HIV) and had a history of anaphylaxis to penicillin developed lues maligna, or ulceronodular secondary syphilis. Therapy with parenteral erythromycin failed, and he was subsequently treated with ceftriaxone following penicillin desensitization. A review of the English-language literature identified 14 cases of lues maligna reported between the early 1900s and 1988. From 1989 to 1994, an additional 12 cases (including the current case) were reported. Of those 12 cases, 11 occurred in patients who either were infected with HIV or were at high risk for HIV infection. Patients infected with HIV may be at increased risk of developing this severe form of secondary syphilis. Lues maligna should be considered in the differential diagnosis of HIV-infected patients who present with ulceronodular lesions.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7742445     DOI: 10.1093/clinids/20.2.387

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  10 in total

Review 1.  Syphilis: review with emphasis on clinical, epidemiologic, and some biologic features.

Authors:  A E Singh; B Romanowski
Journal:  Clin Microbiol Rev       Date:  1999-04       Impact factor: 26.132

2.  [HIV-positive patient with multiple ulcers. Lues maligna].

Authors:  A Körber; J Dissemond; U Hillen; M Goos; St Esser
Journal:  Hautarzt       Date:  2003-11       Impact factor: 0.751

3.  Malignant syphilis in an AIDS patient.

Authors:  T R dos Santos; I J de Castro; M M B Dahia; M C V M de Azevedo; G A R da Silva; R N Motta; J da Cunha Pinto; F R de Almeida Ferry
Journal:  Infection       Date:  2014-11-19       Impact factor: 3.553

4.  Lues maligna in a patient with unknown HIV infection.

Authors:  Claudia Pföhler; Rebecca Koerner; Lutz von Müller; Thomas Vogt; Cornelia S L Müller
Journal:  BMJ Case Rep       Date:  2011-07-27

Review 5.  The immunopathobiology of syphilis: the manifestations and course of syphilis are determined by the level of delayed-type hypersensitivity.

Authors:  J Andrew Carlson; Ganary Dabiri; Bernard Cribier; Stewart Sell
Journal:  Am J Dermatopathol       Date:  2011-07       Impact factor: 1.533

6.  Macrolide Resistance in the Syphilis Spirochete, Treponema pallidum ssp. pallidum: Can We Also Expect Macrolide-Resistant Yaws Strains?

Authors:  David Šmajs; Lenka Paštěková; Linda Grillová
Journal:  Am J Trop Med Hyg       Date:  2015-07-27       Impact factor: 2.345

7.  Malignant syphilis with human immunodeficiency virus infection.

Authors:  Jiby Rajan; P V S Prasad; K Chockalingam; P K Kaviarasan
Journal:  Indian Dermatol Online J       Date:  2011-01

8.  The great impostor: Lues maligna in an HIV-infected male.

Authors:  Alfredo J Mena Lora; Marylee Braniecki; Ayman Nasir; Maximo Brito
Journal:  SAGE Open Med Case Rep       Date:  2017-09-19

Review 9.  Managing drug reactions to sulfonamides and other drugs in HIV infection: desensitization rather than rechallenge?

Authors:  P P Koopmans; D M Burger
Journal:  Pharm World Sci       Date:  1998-12

10.  Human immunodeficiency virus-positive secondary syphilis mimicking cutaneous T-cell lymphoma.

Authors:  Michiko Yamashita; Yoshiyuki Fujii; Keiji Ozaki; Yoshio Urano; Masami Iwasa; Shingen Nakamura; Shiro Fujii; Masahiro Abe; Yasuharu Sato; Tadashi Yoshino
Journal:  Diagn Pathol       Date:  2015-10-08       Impact factor: 2.644

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.